Bioclinica’s core management team comprises industry leaders and experts representing science, medicine, technology, clinical operations, and business facets supporting successful clinical development.
Medical Imaging Leadership
Software Solutions Leadership
Executive Chairman & Chief Executive Officer
Euan Menzies is Executive Chairman & Chief Executive Officer of Bioclinica. In this role, he is focused on growing the business and providing world-class science and service to Bioclinica’s customers.
Prior to his appointment at Bioclinica, Euan spent more than two decades leading vertical market information and software businesses, first as the President & CEO of the Tax & Accounting division of The Thomson Corporation and then as CEO of Vertafore. During his tenure as CEO at Vertafore, Euan led a complete transformation of the business, leading to dramatic improvements in product quality and innovation, customer satisfaction, employee productivity and morale, and financial performance.
Euan also worked with Insight Partners as a Managing Director/Senior Advisor, focusing on investments in vertical market software companies.
Euan was born and raised in Glasgow, Scotland, and after graduating from Glasgow University (B.Acc), he worked with KPMG in Scotland and New York. He qualified as a Chartered Accountant and is a member of the Institute of Chartered Accountants of Scotland (ICAS).
Executive Vice President, Chief Operating Officer
Charles “Chuck” Bodner is Executive Vice President, Chief Operating Officer of Bioclinica. He leads the company’s business operations, including finance, legal, information technology, human resources and corporate development. Chuck also has strategic oversight of the Drug Safety Solutions unit.
With strong professional interests in customer engagement and accelerating profitable top-line growth, Chuck brings more than two decades of healthcare experience to this role. Most recently, he served as Senior Vice President of Finance, Chief Accounting Officer, & CFO of International at BD (Becton, Dickinson and Company). While at BD, he held leadership finance positions in both commercial and corporate organizations. He also has held senior level positions focused on business integration and value capture activities. Prior to BD, Chuck held positions of increasing responsibility at Sanofi, Schering-Plough, and AstraZeneca.
Chuck holds an MBA and BSc in Finance from LaSalle University.
Dan Gebow, PhD
Chief Innovation Officer
Dan Gebow, PhD, is Chief Innovation Officer at Bioclinica. He leads digital transformation initiatives to drive technological change across the medical imaging business and accelerates the investment and productization of new tools for critical insights. He brings more than 18 years of experience in clinical research informatics and 28 years in biomedical research to this role.
Dr. Gebow joined Bioclinica in 2017 following the acquisition of his software company MDDX Research and Informatics, now known as the backbone of SMART Submit. He previously served as Senior Vice President of Research and Development and Vice President of Innovation at Bioclinica.
During his career, Dr. Gebow has brought over ten digital health tools from ideation to commercialization. In addition to numerous patent filings, he has authored several scientific publications, covering a range of topics including medical imaging and cancer genetics. He earned his Doctorate from Harvard University, with course work completed at Harvard Medical School, Harvard School of Public Health, and Massachusetts Institute of Technology (MIT).
Michael O’Neal, MD
Chief Medical Officer
Michael O’Neal, MD, is Chief Medical Officer at Bioclinica. As a key member of the senior executive team, Dr. O’Neal is responsible for overseeing all medical affairs efforts within the organization, providing strategic leadership to clinical teams while collaborating with sponsors in all aspects of medical imaging protocol development. Drawing on extensive clinical experience in internal medicine and diagnostic radiology, he oversees physician training, service quality, and process improvements while advising on medical operations, regulatory compliance, and the investment of new technologies across medical imaging.
During his 17 years with Bioclinica, Dr. O’Neal has developed and championed improved standards that enable research sites to produce comparable study data across the globe and has provided oversight of imaging data for more than 75 regulatory approvals. Throughout his tenure, he has played a central role in protocol review, charter development, a reader on multiple trials, and independent oversight of over 400 clinical trials to date. He is a member of professional organizations including the Radiological Society of North America, the American College of Radiology, the American Medical Association, the Drug Information Association, the American Society for Clinical Oncology, and the American Society of Hematology. In 2019, he was recognized by PharmaVOICE magazine as one of the “100 Most Inspiring People in the Life-Sciences Industry”.
Prior to his role at Bioclinica, Dr. O’Neal served as Chairman for the Department of Radiology at the Hospital Center at Orange and the head of Central Medical Imaging MRI center. Dr. O’Neal holds certification in Diagnostic Radiology from the American College of Radiology, in addition to fellowship training in Body Imaging. He is the author of several papers, a speaker at many industry meetings, and was a contributor to the iRECIST Committee prior to publication.
Senior Vice President, Head of Client Services and Delivery
Bradley Dean is Senior Vice President and Head of Client Services and Delivery at Bioclinica. Leveraging more than 18 years of technical and management experience, Bradley leads the global services, project management, operations and clinical data management teams responsible for the planning, oversight, and service delivery for all medical imaging studies across the Bioclinica therapeutic areas. Under his leadership, he heads up a specialized collaboration committed to the company’s largest enterprise sponsors. Through mentorship and innovation, Bradley and his team excel at safeguarding the quality of service, compliance and data quality, and process improvement and standardization at Bioclinica.
During his two-decade tenure, Bradley held positions of increasing responsibility in project and program management, pricing and proposals, mergers and acquisitions, and enterprise sponsors and portfolio management. Prior to joining Bioclinica, he served as Program Director at WorldCare Clinical and as Project Manager and Operations Lead at Parexel.
Bradley earned his bachelor’s degree in environmental population organismic biology from the University of Colorado at Boulder and a master’s degree in business administration from Boston University. After his undergraduate studies, he served in the United States Peace Corps for two years in Africa where he taught more than 500 students practical and theoretical components of biology.
Senior Vice President, Global Business Development
Eric Forsthoffer is Senior Vice President of Global Business Development at Bioclinica. As a key member of the senior executive team, he oversees the management, service harmonization, and success of Global Business Development and Marketing for Medical Imaging and Cardiac Safety. Leveraging a deep understanding and knowledge of clients’ needs for their clinical trials, Eric works closely to improve business performance, satisfaction, and efficiencies while growing Bioclinica’s strong presence and leadership in the market.
Eric began his 18-year tenure at Bioclinica as a temp and then held positions of increasing responsibility in site administration, project management, and business development, supporting all therapeutic areas at Bioclinica. He has contributed to the development of the gastrointestinal (GI) program by leading activities on prototype development and deployment on the first GI study for video capture, with more than 60 studies currently.
In his past roles, Eric served as a Randomization and Trial Supply Management (RTSM) Project Manager, Senior Project Manager, and Account Manager at Signant Health (formerly United BioSource Corporation) before returning to Bioclinica to serve in key leadership positions in 2011. He was also a contributing author for Medical Imaging in Clinical Trials, which focused on best practices for evaluating imaging core labs that were consistent with Good Clinical Practice (GCP) and regulatory compliance. Eric earned his associate degree in business and commerce from Arizona State University.
Senior Vice President, Quality Assurance & Regulatory Compliance
Todd Kisner is a recognized clinical research industry senior executive with more than 20 years of experience in the pharmaceutical and technical industries. As the Senior Vice President, Quality Assurance and Regulatory Compliance, he oversees the Corporate Quality Management System, Regulatory Compliance and Records Management groups at Bioclinica. He holds responsibility for ensuring Bioclinica and its products and services comply with international regulatory standards, industry best-practices and leads retrospective oversight activities. Todd has held numerous positions of increasing responsibility and joined Bioclinica as the Vice President of Quality and Regulatory Affairs in 2013. Prior to joining the Company he was responsible for Quality Assurance and Regulatory Compliance with CoreLab Partners and the Director of Quality Assurance with Medifacts International. Todd has held key validation and technical roles at SAS Institute and Thomson Reuters. Additionally he has been a contributor to the Metrics Champion Consortium for both ECG and Imaging, and has extensive experience in data privacy regulation, 21 CFR Part 11, GxP, Quality Assurance, SDLC and Validation Services. He holds an organizational excellence ASQ certification and sits on industry Global Data Protection and Privacy Committees, Ethics & Regulatory Compliance Committees, and GCP Quality Management System work streams.
President, Software Solutions
Guy Crossley is President of Software Solutions at Bioclinica. In this role, he is focused on delivering innovation in clinical trial software for global clients.
Guy has extensive experience in developing customer-centric software and technology solutions in the healthcare and technology space. In senior management roles, Guy has managed geographically and functionally dispersed groups of technology, commercial, delivery, and administrative professionals through mergers, acquisitions and industry disruption. Most recently, he served as Vice President of Product Development at R1 RCM, a provider of technology-enabled revenue cycle services for hospitals, health systems, and physician groups. Prior to R1 RCM, he was President of WPC Healthcare, a healthcare data science company providing data solutions for hospitals and other healthcare stakeholders.
Guy is active in the local Nashville community and has served on boards of both industry and community service organizations such as SIIA (Software & Information Industry Association) and Maryland Farms YMCA in Tennessee. He graduated from the University of Arkansas at Little Rock with a Bachelor’s degree in Business Administration and Finance.
President, Drug Safety Solutions
As President, Drug Safety Solutions, and a member of Bioclinica’s executive leadership team, Humaira Qureshi leads the strategic planning and execution of our global drug safety and pharmacovigilance (PV) business. In addition to working in close collaboration with our global PV clients, Humaira oversees all program operational, commercial, and global resourcing aspects. She brings to the role over 20 years experience in clinical and post marketing safety; both strategic and operational. Humaira has demonstrated success in delivery and implementation of PV operational solutions for several top ten global pharmaceutical companies. Prior to joining Bioclinica in 2018, Humaira established and led the global pharmacovigilance business for a London-based company. During her nine years there she demonstrated exceptional customer service management and global resource management skills, delivering numerous large-scale PV engagements. Humaira has participated on a number of Global PV forums focusing on technology, sourcing and process enablement. Humaira is frequently invited to lecture and has presented on a range of PV topics before thousands at industry and academic events in the US, EU, and Asia. Humaira has a Bachelor’s degree in Medicinal Biochemistry from Royal Holloway, University of London.
Executive Vice President, General Counsel & Chief Compliance Officer
Chris is a senior legal executive with over 23 years of experience, including serving as a strategic counsel to boards-of-directors and senior management on clinical trial matters. Prior to joining Bioclinica, Chris was Vice President and General Counsel for the BioPharma Services Division (BSD) at Thermo Fisher Scientific where he oversaw all legal matters globally for the clinical trial businesses. His responsibilities included managing commercial transactions, contracting, claims and litigation, data privacy, global trade compliance (import / export), regulatory compliance, and risk management for BSD. Prior to this, Chris was Senior Vice President, General Counsel and Corporate Secretary at Comprehensive NeuroScience, Inc., which provided clinical trials, care management technology, and medical education services to life science companies. Chris earned a bachelor’s degree in Pharmacy from St. John’s University College of Pharmacy and Allied Health. While practicing as a Registered Pharmacist in hospital and retail settings, he earned his law degree from St. John’s University School of Law. Chris is a member of the bar in New York, New Jersey and Connecticut, and holds an in-house counsel license in the Commonwealth of Pennsylvania. He also is a member of the Association of Corporate Counsel and the International Association for Contract & Commercial Management..
Chief Financial Officer
Maureen Marchek is Chief Financial Officer at Bioclinica. In this role, Maureen leads and oversees all financial operations, accounting, financial planning and analysis, real estate, internal audit and tax functions for Bioclinica.
Maureen joined Bioclinica in 2014 as Finance Director and was then promoted to Corporate Controller in 2015 and Senior Vice President of Finance in 2020.
Prior to Joining Bioclinica, Maureen spent 14 years at PricewaterhouseCoopers (PwC) in their audit practice. While at PwC, she had her first experience with Bioclinica, where she was the senior manager on the Bioclinica audit engagement team.
Maureen earned her bachelor’s degree in Accounting from Villanova University and is a certified Public Accountant.
Thomas Fuerst, PhD
Chief Science Officer
Dr. Thomas Fuerst leads the design and scientific oversight of musculoskeletal clinical trials for Bioclinica. Dr. Fuerst received his Ph.D. in medical physics from the University of Wisconsin at Madison and has more than 13 years of research experience in bone densitometry, vertebral fracture methods and body composition assessment with a focus on multicenter clinical trials. Prior to joining Bioclinica, he was a faculty member of the University of California, San Francisco, where he served as Director of the Quality Assurance Center and as Associate Director of the Osteoporosis and Arthritis Research Group (OARG). While at UCSF, he successfully coordinated the collection, quality control and centralized analysis of densitometry scans and imaging data for international, multi-center Phase II and Phase III clinical trials. Dr. Fuerst is also the co-founder of the imaging core lab Synarc, where he served as Scientific Director.
As an active member of the International Committee for Standards in Bone Measurement, Dr. Fuerst has worked to improve, standardize, and advance bone density technologies. He routinely consults with industry and government agencies on the use of DXA to evaluate bone mineral density and body composition.
Joyce Suhy, PhD
Senior Vice President, Medical Imaging
Dr. Joyce Suhy is responsible for the Neuroscience and Cardiovascular Services at Bioclinica. Dr. Suhy leads the design and scientific oversight of the imaging endpoints for these clinical trials and provides training to staff involved in these studies. Dr. Suhy has authored numerous journal articles and book chapters in imaging of the brain since 1992. Prior to joining Bioclinica, Dr. Suhy worked at Synarc, where she was the VP of Neuroscience, and at SurroMed, Inc. where she was a Clinical Research Specialist responsible for the development, design, and evaluation of a standardized protocol for multiple sclerosis. Dr. Suhy received her Bachelor’s degree in Chemistry from Northwestern University and her PhD in Biochemistry from Loyola University Chicago. She completed her Post-Doctoral Research Fellowship in the Department of Radiology at the University of California at San Francisco where her work focused on utilizing MR spectroscopy and imaging to quantify metabolites within the human brain as a method to diagnose and predict the onset of neurodegenerative diseases such as epilepsy, multiple sclerosis, Alzheimer’s disease and amyotrophic lateral sclerosis. Dr. Suhy is a recipient of many honors and grant awards including a Co-Principal Investigator NIH RO1 Grant, a Principal Investigator NIH National Research Service Award and a Principal Investigator National MS Society Fellowship. She has authored numerous journal articles and book chapters in the neuroscience therapeutic area and has participated on several expert panels to advance the use of imaging in clinical trials.
Julie Cole, MD
VP, Medical Imaging, Oncology
Julie Cole (formerly Julie Barudin) received a B.S.E. in Electrical Engineering and Computer Science (cum laude) from Princeton University, and an M.D. from the College of Physicians and Surgeons of Columbia University. She completed a residency in diagnostic radiology at New York University Medical Center, with fellowships in Body Imaging and Women’s Imaging. She is licensed in New Jersey, New York, Pennsylvania and Delaware and board certified by the American Board of Diagnostic Radiology.
Following training, Dr. Cole served as Assistant Professor of Radiology, Ultrasound Division, at NYU Medical Center, and subsequently as Assistant Professor of Radiology, Breast Imaging Division, at the University of Pennsylvania School of Medicine. Before joining BioClinica in 2004, she worked in clinical women’s imaging at Hackensack University Medical Center and at Orange Regional Medical Center where she served as Director of Women’s Imaging.
She has contributed to presentations at the RSNA, and has co-authored articles published in Breast Disease and Preventive Medicine journals as well as chapters on breast imaging for multiple radiology textbooks.
Robert Ford, MD
Senior Advisor, Chief Medical Officer Emeritus
Robert R. Ford, MD, joined Bioclinica in 2020 as a Senior Advisor, Chief Medical Officer Emeritus. In this role, Dr. Ford consults with customers, is responsible for the medical and scientific publication process at Bioclinica, and oversees FDA and regulatory guidance and reader metrics.
Dr. Ford brings more than three decades of clinical experience to Bioclinica after practicing as a radiologist at Princeton Radiology Associates. He also served in various consulting roles and as a clinical instructor throughout the Northeast.
Prior to joining Bioclinica, Dr. Ford founded Clinical Trials Imaging Consulting, LLC, a company specializing in providing consulting services in the area of medical imaging (radiology) in all aspects of drug development. Dr. Ford, was also the founder of RadPharm, an imaging core lab dedicated to the independent review of diagnostic imaging studies for pharmaceutical, biotech and regulatory agencies. During his various consultancies, he helped support the approval of multiple drugs including, but not limited to Herceptin, Eloxatin, Velcade, Sutent, Vectibix, Ixempra, Treanda, Doxil, Avastin and Pegloticase.
Dr. Ford is an author of the Response Evaluation Criteria of Solid Tumors (RECIST 1.1), and the Guidelines for Response Criteria for Use in Trials Testing Immunotherapeutics (iRECIST), both internationally accepted Response Criteria used to standardize patient response to therapy.
He received his B.S. degree from Rutgers University, his MD degree from Robert Wood Johnson Medical School and completed an internship in Internal Medicine and subsequently training in Diagnostic Radiology at Cornell University Medical Center-New York Hospital, Memorial Sloan Kettering Cancer Center, and the Hospital for Special Surgery.
Vice President, Global Business Development, Software Solutions
Richard Murg is Vice President of Global Business Development for Software Solutions at Bioclinica. As a key member of the leadership team, Rich is responsible for sales and marketing with influence in the operations and development of the products and services.
Rich originally joined Bioclinica in 2006 as the West Coast Account Executive. Taking what he learned in the Western region, he was appointed to Vice President of Sales Mid-Markets.
Rich briefly left Bioclinica in 2017 to serve as Chief Revenue Officer at MedNet Solutions. Before returning to Bioclinica, he led MedNet’s sales team to record bookings, delivering 25 percent growth. He held sales positions at Interwoven, Liquent and FileNet and began his career in finance as an analyst at Disney.
He is a graduate of the United States Military Academy, West Point, and has earned a master’s degree in Business Administration from the University of Texas, El Paso. Rich is a former Army Officer and war veteran.
Vice President, Service Delivery, Software Solutions
Ajith Gopalakrishnan is Vice President of Service Delivery for Software Solutions at Bioclinica. As a key member of the senior executive team, Ajith is responsible for the customer experience via onboarding and implementations through ongoing service delivery and technical support. Through his strategic leadership, Ajith’s team delivers superior customer service designed to position customers for long-term success.
An accomplished technology services leader, Ajith has more than 20 years of experience in leveraging technology to drive growth and productivity. He has rich experience in designing and delivering technology solutions to drive customer acquisition and growth, and improve operational efficiencies across Life Sciences, Insurance, Retail/CPG and Hi-Tech industries.
Prior to his role at Bioclinica, Ajith served as Vice President of Customer Success at Comprehend Systems, where he led the customer success, professional services, and customer support teams. Under his leadership, the Customer Success organization delivered clinical trial analytics solutions to pharmaceutical companies and contract research organizations. He was instrumental in growing the team, upgrading its capabilities, and accelerating service delivery timelines. Prior to his role at Comprehend Systems, he was Senior Vice President of Insights Delivery and Operations at Motista where he drove the development and implementation of scalable processes and technology to deliver data driven insights to customers that drove growth and improved operations. As Vice President of Professional Services at Saama, he led a global team of 800 to deliver advanced analytics solutions to Fortune 1000 companies. He was instrumental in adding new service capabilities, evangelizing machine learning solutions, and growing revenues.
Ajith graduated from the Indian Institute of Technology, Madras with a bachelor’s degree in Electrical and Electronics Engineering.
Vice President, Enabled Client Services
Kevin is a recognized clinical research senior executive with more than 30 years of operational and business leadership experience, the last 20 years of which have been in the high-growth eClinical technology space. In his current role, Kevin is responsible for driving the growth strategy for the Randomization & Trial Supply Management (RTSM) business, encompassing Bioclinica’s innovative IRT platform, clinical supply forecasting, optimization and planning services, as well as further developing Bioclinica’s unique project delivery methodology. Prior to Bioclinica Kevin led the RTSM and clinical logistics solution business at PAREXEL Informatics. Before that, Kevin was with ClinPhone for ten years focused on RTSM and other eClinical solutions before being acquisition by PAREXEL in 2008. Kevin has lived in the USA since 1999 when he relocated from the United Kingdom to facilitate the establishment of ClinPhone’s business and North American operations. Prior to this he spent approximately ten years managing the execution of clinical development plans for various multinational pharmaceutical companies spanning all stages of pre-clinical and clinical research. Kevin has a Bachelor’s degree in Physiology and Pharmacology from the University of Southampton (UK).
Vice President, Software Engineering
Douglas Cory is Vice President of Software Engineering at Bioclinica. In this role, Doug oversees technology services, development support, and product development teams. Leveraging a deep background in software development and leadership, Doug provides strategic guidance on application solutions, architectures, integration strategies, governance, quality assurance, and business support at Bioclinica. He is responsible for software product expansion and development across global markets, working closely with the Software Solutions leadership team to help customers achieve their clinical research goals.
Doug was recently appointed to the position of Vice President, Software Engineering, and rejoins Bioclinica after spending two years with East Bay Software. During his time as President of East Bay Software, he launched the development of web-based tools for Electronic Data Capture and for design, setup, testing, and maintenance of studies within various tools.
In his prior role at Bioclinica, he served as Vice President, eClinical Solutions Development, where he oversaw the software development teams across Bioclinica’s eClinical division.
Doug was a founder of Phoenix Data Systems, Inc. (now a part of Bioclinica) and served for a time as President. Over the last 25 years, he has held various positions at SmithKline Beecham, the New England Medical Center Hospital, and Synectechs. He received his bachelor’s degree in Applied Mathematics and his master’s degree in Statistics from the University of Rhode Island.
Vice President, Product Management, Software Solutions
Kapi Patel is Vice President of Product Management at Bioclinica. As a key member of the senior executive team, Kapi’s focus is to drive product strategy and innovation for the Bioclinica Software Solutions product portfolio, working cross-functionally across the various functions within Bioclinica.
Kapi has a versatile background with extensive software development and operational leadership experience with all aspects of the product delivery lifecycle. She is an accomplished leader delivering technology solutions to achieve strategic goals and customer satisfaction. Kapi previously served as Director of IT Operations & Product Development at Bioclinica for five years. In this role, she established portfolio reporting, provided product management leadership, led multiple strategic initiatives, and drove process improvements and operational efficiencies.
Prior to joining Bioclinica, Kapi served as Vice President, Solutions & Technology, at ProtonMedia Inc., where she successfully led software development, customer success, application support, professional services, and IT infrastructure. Previously, she also spent almost two decades leading software development projects. Kapi received a Higher National Certificate (HNC) in Computer Science from Croydon Technical College in the United Kingdom (UK).
Director of Validation Services, Software Solutions
Abhishek Prasad is Director of Validation Services for Software Solutions at Bioclinica. In this role, he is responsible for managing and mentoring a globally distributed validation team to respond effectively to the business needs at Bioclinica.
By establishing effective measures to improve the Validation Services team’s productivity, Abhishek enhances software quality while driving operational excellence. He works closely with Bioclinica’s Quality Assurance and Regulatory Compliance team to ensure core products and services adhere to standard operating procedures and regulatory guidelines.
Under his leadership, he ensures the quality of Bioclinica products and enabled client services by establishing validation standards and processes throughout the software development lifecycle, including integration level testing, regression testing, system testing, test automation , and performance testing through effective, streamlined strategies.
A seasoned leader, Abhishek joined Bioclinica in 2010 and has served in various roles of increasing responsibility. Prior to his current role, Abhishek served as Group Leader of Validation Services, where he helped lead validation of eClinical products while also helping establish validation processes for the Drug Safety Solutions business unit. He also served as an interim product manager for Bioclinica IRT.
Abhishek earned his master’s degree in Industrial Engineering from West Virginia University and a bachelor’s degree in Engineering from Visweswariah Technological University. He is also a member of Society of Quality Assurance and American Society for Quality.